RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Covalent organic frameworks as nanocarriers of tailored BODIPY for phototheragnostic applications
[EN] Grafting fluorophores and photosensitizers onto nanocarriers is recognized as an effective strategy for fluorescent bioimaging and photodynamic therapy. This approach enhances targeted drug delivery to tumor sites, while improving the biocompatibility and stability of poorly water-soluble bioprobes, thereby reducing side effects. Among the available organic dyes and nanoparticles, BODIPY and COF stand out as a compatible pair for this purpose. To leverage the COF-BODIPY scaffold as a photoactive platform for biomedical applications, we have optimized their integration. To this aim, first, BODIPY units were functionalized to enable strong binding to specific sites of the COF via click chemistry, positioning the BODIPY within the pores of the COF. Following this approach, BODIPY derivatives photoactive across different spectral regions (from the green to the red window) were straightforwardly grafted onto the COF. The structural and photophysical properties of these nanomaterials were thoroughly characterized. Notably, the COF bearing styrylated and iodinated BODIPY was especially appealing due to its dual photonic performance, enabling both singlet oxygen generation and red fluorescence under long-wavelength excitation. Upon its cellular uptake by human melanoma cells, this dyed nanoparticle selectively stained lysosomes, and at the same time triggered a cytotoxic response to induce cell death under illumination with red light, thus being a suitable candidate for theragnostic purposes., This research was supported by projects: TED2021-129886B-C43 granted by MCIN/AEI/10.13039/501100011033 and the European Union NextGeneration EU/PRTR; PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe; PID2022-138908NB-C33 and PID2024-157648-NB-C22 granted by MICIU/AEI/10.13039/501100011033 and FEDER, UE. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) and Gobierno Vasco (IT1639-22). The work was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. L. S. acknowledges the MICIIN for the REDES project "RED2022-134503-T". P. M. S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). J. I. M. acknowledges funding from Spanish MCIN (Grants PID2023-149077OB-C31, TED2021-12941A-I00 and PLEC2021-007906 funded by MCIN/AEI/10.13039/501100011033 and by the "European Union NextGenerationEU/PRTR"), and Comunidad de Madrid (Grant TEC-2024/TEC-459). The Severo Ochoa Centres of Excellence program through Grant CEX2024-001445-S is also acknowledged.
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PLEC2021-007906
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126304OB-C41
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-128141OB-C22
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-138908NB-C33
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2023-149077OB-C31
,
Generalitat Valenciana INVEST/2023/443
,
Generalitat Valenciana CIPROM/2021/007
,
Eusko Jaurlaritza IT1639-22
,
Centro de Investigación Biomédica en Red CB06/01/2012
,
Agencia Estatal de Investigación TED2021-129886B-C43
,
Agencia Estatal de Investigación TED2021-12941A-I00
,
Agencia Estatal de Investigación PID2024-157648-NB-C22
,
Agencia Estatal de Investigación CEX2024-001445-S
,
Ministerio de Ciencia e Innovación RED2022-134503-T